西麥食品(002956.SZ):募投項目江蘇西麥燕麥食品生產基地建設項目(一期)建成投產
格隆匯5月7日丨西麥食品(002956.SZ)公佈,公司首次公開發行股票並上市募集資金投資項目之一的“江蘇西麥燕麥食品生產基地建設項目(一期)”由子公司江蘇西麥食品有限責任公司具體實施,規劃總投資額為1.5億元,其中使用募集資金金額1.02億元,差額部分由公司自有資金補足。
2020年5月7日,“江蘇西麥燕麥食品生產基地建設項目(一期)”已正式投產運行。
該項目正式投產後將進一步提升公司產能,為公司銷售規模不斷擴大提供產能支持,形成規模經濟效應,有利於降低生產成本,進而提升公司整體綜合實力,增強公司盈利能力和持續發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.